Bourgeon Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,500
Closed -$22K 313
2020
Q4
$22K Buy
+4,500
New +$22K 0.01% 184
2020
Q3
Sell
-11,850
Closed -$80K 324
2020
Q2
$80K Buy
11,850
+9,850
+493% +$66.5K 0.03% 100
2020
Q1
$13K Buy
2,000
+250
+14% +$1.63K 0.01% 173
2019
Q4
$18K Sell
1,750
-10,050
-85% -$103K 0.01% 157
2019
Q3
$46K Sell
11,800
-700
-6% -$2.73K 0.02% 118
2019
Q2
$186K Buy
+12,500
New +$186K 0.11% 68
2019
Q1
Sell
-12,450
Closed -$224K 81
2018
Q4
$224K Sell
12,450
-1,700
-12% -$30.6K 0.15% 57
2018
Q3
$416K Buy
14,150
+800
+6% +$23.5K 0.21% 57
2018
Q2
$607K Hold
13,350
0.33% 50
2018
Q1
$705K Buy
13,350
+3,600
+37% +$190K 0.39% 50
2017
Q4
$663K Sell
9,750
-825
-8% -$56.1K 0.36% 51
2017
Q3
$871K Buy
10,575
+1,600
+18% +$132K 0.51% 41
2017
Q2
$840K Buy
8,975
+4,725
+111% +$442K 0.53% 39
2017
Q1
$271K Sell
4,250
-1,000
-19% -$63.8K 0.17% 68
2016
Q4
$233K Sell
5,250
-9,600
-65% -$426K 0.15% 77
2016
Q3
$535K Buy
14,850
+1,000
+7% +$36K 0.34% 59
2016
Q2
$190K Sell
13,850
-10,650
-43% -$146K 0.12% 83
2016
Q1
$470K Buy
24,500
+6,350
+35% +$122K 0.31% 60
2015
Q4
$635K Buy
+18,150
New +$635K 0.41% 53
2015
Q3
Sell
-3,150
Closed -$277K 113
2015
Q2
$277K Hold
3,150
0.17% 93
2015
Q1
$234K Sell
3,150
-19,600
-86% -$1.46M 0.14% 97
2014
Q4
$1.27M Sell
22,750
-8,800
-28% -$493K 0.78% 44
2014
Q3
$1.43M Buy
31,550
+11,450
+57% +$519K 0.83% 43
2014
Q2
$832K Buy
+20,100
New +$832K 0.45% 57
2014
Q1
Sell
-7,500
Closed -$452K 106
2013
Q4
$452K Buy
+7,500
New +$452K 0.29% 72